We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

78 hedge funds and large institutions have $203M invested in Utah Medical Products in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

11% more capital invested

Capital invested by funds: $182M → $203M (+$20.6M)

5% more funds holding

Funds holding: 74 → 78 (+4)

0.45% more ownership

Funds ownership: 66.68% → 67.14% (+0.45%)

Holders
78
Holders Change
+4
Holders Change %
+5.41%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
33
Reduced
21
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TAM
THB Asset Management
Connecticut
+$3.4M
2
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.65M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.48M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.08M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$835K

Top Sellers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
-$4.93M
2
BIP
Brandes Investment Partners
California
-$2.87M
3
NFA
Nationwide Fund Advisors
Ohio
-$888K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$702K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$353K
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
26
US Bancorp
Minnesota
$1M +$9.37K +120 +1%
OAM
27
Oxford Asset Management
United Kingdom
$977K -$112K -1,432 -10%
TCIM
28
TIAA CREF Investment Management
New York
$897K +$138K +1,762 +19%
IP
29
Isthmus Partners
Wisconsin
$893K +$5.78K +74 +0.7%
B
30
Bailard
California
$816K +$783K +10,030 New
CCMINC
31
Cardinal Capital Management Inc (North Carolina)
North Carolina
$806K -$4.84K -62 -0.6%
Two Sigma Investments
32
Two Sigma Investments
New York
$715K +$43.8K +561 +7%
UBS Group
33
UBS Group
Switzerland
$633K -$51K -653 -8%
Bessemer Group
34
Bessemer Group
New Jersey
$586K -$39K -500 -6%
Allianz Asset Management
35
Allianz Asset Management
Germany
$564K +$541K +6,930 New
Charles Schwab
36
Charles Schwab
California
$535K -$88.6K -1,135 -15%
Millennium Management
37
Millennium Management
New York
$520K -$322K -4,125 -39%
TA
38
Teachers Advisors
New York
$484K – – –
SCP
39
Seizert Capital Partners
Michigan
$464K -$63.1K -808 -12%
Janney Montgomery Scott
40
Janney Montgomery Scott
Pennsylvania
$462K -$14.8K -189 -3%
Citigroup
41
Citigroup
New York
$454K +$151K +1,936 +53%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$438K -$5.54K -71 -1%
TA
43
Teton Advisors
New York
$407K – – –
WCM
44
Wedge Capital Management
North Carolina
$399K – – –
SO
45
STRS Ohio
Ohio
$341K +$117K +1,500 +56%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$326K – – –
PIM
47
Penobscot Investment Management
Massachusetts
$326K – – –
RHJA
48
Rice Hall James & Associates
California
$315K +$3.2K +41 +1%
CI
49
Cigna Investments
Connecticut
$305K – – –
FQ
50
First Quadrant
California
$305K – – –
1
2
3 4

UTMD Hedge Fund Activity: Q4 2017 in Review

78 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2017, worth a combined $203M — up 11% from $182M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new UTMD positions and 6 closed out — a net gain of 4 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was THB Asset Management, opening a new position worth an estimated $3.4M. The largest seller was American Century Companies, exiting entirely with an estimated $4.93M sold.

  • 78 institutional investors held Utah Medical Products (UTMD) as of Q4 2017, up from 74 in Q3 2017.
  • Funds reported $203M of Utah Medical Products stock for Q4 2017, up 11% quarter-over-quarter.
  • 10 funds opened new Utah Medical Products positions in Q4 2017 and 6 closed out, a net change of +4 holders.
  • The largest Utah Medical Products buyer in Q4 2017 was THB Asset Management, an estimated $3.4M added.
  • The largest Utah Medical Products seller in Q4 2017 was American Century Companies, an estimated $4.93M sold.

Based on aggregated 13F filings for Q4 2017.